The GSK3B Knockout CAL-27 Polyclonal Cells represent a pooled population of CAL-27 human tongue squamous cell carcinoma cells that have undergone CRISPR/Cas9-mediated disruption of the GSK3B gene. This polyclonal knockout product provides a heterogeneous loss-of-function model for investigating the cellular roles of glycogen synthase kinase-3 beta (GSK3B) in an epithelial cancer background. The targeted gene disruption abrogates GSK3B protein expression and enables systematic analysis of downstream signaling networks and phenotypic changes in a disease-relevant cellular context.
The CAL-27 host cell line is an established adherent epithelial model isolated from a primary tongue squamous cell carcinoma of a 56-year-old male patient. These cells harbor genetic alterations characteristic of aggressive oral squamous cell carcinoma, including a TP53 mutation and dysregulation of growth factor signaling. CAL-27 cells are widely employed to study tumor cell proliferation, invasion, and therapeutic resistance, making them a clinically relevant platform for functional genomics studies targeting oncogenic signaling pathways.
GSK3B functions as a constitutively active serine/threonine kinase that plays a central role in multiple signaling cascades. In the absence of Wnt ligands, GSK3B associates with Axin, APC, and PP2A in the destruction complex, phosphorylating ??-catenin to promote its ubiquitin-mediated proteasomal degradation. Upon Wnt stimulation, Frizzled and Dishevelled transduce signals that inhibit GSK3B activity via FRAT-dependent mechanisms, leading to ??-catenin stabilization and nuclear translocation, where it complexes with TCF/LEF to drive transcription of target genes such as c-Myc and cyclin D1. GSK3B also integrates inputs from insulin and growth factors through the PI3K-Akt signaling axis, which phosphorylates and inactivates GSK3B. In turn, GSK3B regulates additional downstream effectors including Snail and NF-??B, modulating cellular processes from metabolism to inflammation.
In CAL-27 oral squamous cell carcinoma cells, GSK3B occupies a critical node linking oncogenic Wnt/??-catenin signaling with tumor cell proliferation, survival, and metastasis. Disruption of GSK3B in this background enables researchers to dissect its context-dependent functions, as GSK3B exhibits both tumor-suppressive and tumor-promoting activities depending on the signaling milieu. This polyclonal knockout population facilitates the study of ??-catenin-dependent and -independent effects on cell cycle progression, apoptotic regulation, and epithelial-mesenchymal transition, providing insights into the molecular underpinnings of oral cancer aggressiveness.
This gene-edited cell model is suited for a range of experimental applications, including mechanistic studies of Wnt/??-catenin pathway dynamics using TOP/FOP flash reporter assays and immunofluorescence, as well as functional assessments of tumor cell behavior via proliferation, migration, and invasion assays. The cells provide a robust system for pharmacological screening of GSK3B inhibitors or Wnt pathway modulators and for validating downstream target expression by western blotting. Combining the polyclonal knockout approach with the CAL-27 oral cancer background enables exploration of the interplay between GSK3B loss and compensatory signaling mechanisms. For further details, please contact Ascent Research.
